Literature DB >> 7690758

Modeling study of antibody combining sites to (alpha 1-6)dextrans. Predictions of the conformational contribution of VL-CDR3 and J kappa segments to groove-type combining sites.

D Wang1, J M Hubbard, E A Kabat.   

Abstract

The shuffling of the V kappa-Ox1 light chain joined to J kappa 4 of J kappa 5 instead of J kappa 2 reduced or abolished antigen binding of three groove-type anti-(alpha 1-6)dextran monoclonal antibodies, raising questions as to the structural roles of J kappa in antibody combining sites. The J kappa 4 light chain used contains Pro95A at the V kappa-Ox1-J kappa 4 junction, as well as a Phe to Ile substitution at the beginning of this J kappa 4 segment. To predict whether the defect in antigen binding is a consequence of the J kappa replacement, the Pro insertion or the Phe to Ile substitution, model-building studies were performed. As shown by the surface representation of antibody combining sites, the models with length variation in the VL-CDR3 loop by only 1 residue altered the shape of the combining site dramatically; whereas those with replacement of J kappa or having amino acid substitutions in VL-CDR3 affect the combining site less extensively. A distinct loop configuration of VL-CDR3 appears in models having either a Pro, Gly, or Ala insertion at position 95A. These results indicate that the length of VL-CDR3 is crucial for its loop conformation and may, therefore, have played a major role in abolishing dextran binding activity of the J kappa 4 variants. The potential of V kappa-Ox1 genes in generating conformational diversity in the loop of VL-CDR3 and its influence in forming different combining sites are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690758

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Structural requirements of the major protective antibody to Haemophilus influenzae type b.

Authors:  L Hougs; L Juul; A Svejgaard; T Barington
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Potential impact of the non-human sialic acid N-glycolylneuraminic acid on transplant rejection risk.

Authors:  Vered Padler-Karavani; Ajit Varki
Journal:  Xenotransplantation       Date:  2011 Jan-Feb       Impact factor: 3.907

3.  IL-7 Enables Antibody Responses to Bacterial Polysaccharides by Promoting B Cell Receptor Diversity.

Authors:  Gregory S Dickinson; Eric A Levenson; Justin A Walker; John F Kearney; Kishore R Alugupalli
Journal:  J Immunol       Date:  2018-07-13       Impact factor: 5.422

4.  Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.

Authors:  Annie N Samraj; Kimberly A Bertrand; Robert Luben; Zahra Khedri; Hai Yu; Dzung Nguyen; Christopher J Gregg; Sandra L Diaz; Sherilyn Sawyer; Xi Chen; Heather Eliassen; Vered Padler-Karavani; Kana Wu; Kay-Tee Khaw; Walter Willett; Ajit Varki
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

Review 5.  From "Serum Sickness" to "Xenosialitis": Past, Present, and Future Significance of the Non-human Sialic Acid Neu5Gc.

Authors:  Chirag Dhar; Aniruddha Sasmal; Ajit Varki
Journal:  Front Immunol       Date:  2019-04-17       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.